NCCN 2012 Webinar Series: Women’s Health - Management of Hormone Receptor Negative Disease in Breast Cancer

September 27, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Discuss emerging clinical trial data for triple negative breast cancers
  • Apply the results of emerging clinical trial data to optimize outcome for patients with HER2-positive or triple negative breast cancer
Additional information
Supporters: 

This activity is supported by an educational donation provided by Amgen.
This activity is supported by educational grants from Genentech and Genomic Health, Inc.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
09/27/2012
Course expires: 
12/11/2012
Event starts: 
09/27/2012 - 12:15pm
Event ends: 
09/27/2012 - 1:15pm
Cost:
$0.00

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
09/27/2012
Course expires: 
12/11/2012

Price

Cost:
$0.00
Please login or register to take this course.